At least 45 companies around the world are trying to develop anti-obesity drugs, seeking magic bullets that could help people control their weight. One such drug, Xenical, recently went on sale in Europe and Asia, and it could be licensed in the United States within months. In a world where a blockbuster drug is one that has yearly sales of $1 billion, analysts give $5 billion as a low estimate for an obesity drug.